HC Q study #74
See all studies
Late treatment study
Ba┼×aran et al., Turk. J. Med. Sci., doi:10.3906/sag-2006-173 (Peer Reviewed)
Outcome of Non-Critical COVID-19 Patients with Early Hospitalization and Early Antiviral Treatment Outside the ICU
Observational study of 174 hospitalized patients in Turkey, median age 45.4, 23 treated with HC Q, 113 with HC Q+AZ, and 32 with regimens including favipiravir. 75% reduction in the median time to clinical improvement for HC Q+AZ vs. FAV, RR 0.25, p<0.001. 83% reduction for HC Q. However, there was significant confounding by indication.
There were no significant adverse events.
Source   Share   Tweet
See all studies
Please send us corrections, updates, or comments.